Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Thomas

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
International Journal for Parasitology|February 19, 1998
Vaccination against Babesia bovis: T cells from protected and unprotected animals show different cytokine profilesI J East, H Zakrzewski, K R Gale, et al.
Genetics|July 3, 2007
Epistasis between calpain 1 and its inhibitor calpastatin within breeds of cattleW Barendse, B E Harrison, R J Hawken, et al.
Scientific Reports|February 20, 2013
Implications of temperature variation for malaria parasite development across AfricaJ I Blanford, S Blanford, R G Crane, et al.
Biochemical Society Transactions|May 22, 2007
Self-assembling layers created by membrane proteins on goldD S Shah, M B Thomas, S Phillips, et al.
British Journal of Cancer|August 30, 2008
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancerP M Hoff, S Kopetz, M B Thomas, et al.
Nephron|January 1, 1992
Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failureA St John, M B Thomas, C P Davies, et al.
Oncogene|February 19, 1998
Characterization of the mouse Ron/Stk receptor tyrosine kinase geneS E Waltz, C L Toms, S A McDowell, et al.
Oncology|February 14, 2012
Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trialAhmed O Kaseb, E Garrett-Mayer, J S Morris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinomaM Simonelli, P Zucali, A Santoro, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
International Journal for Parasitology|February 19, 1998
Vaccination against Babesia bovis: T cells from protected and unprotected animals show different cytokine profilesI J East, H Zakrzewski, K R Gale, et al.
Genetics|July 3, 2007
Epistasis between calpain 1 and its inhibitor calpastatin within breeds of cattleW Barendse, B E Harrison, R J Hawken, et al.
Scientific Reports|February 20, 2013
Implications of temperature variation for malaria parasite development across AfricaJ I Blanford, S Blanford, R G Crane, et al.
Biochemical Society Transactions|May 22, 2007
Self-assembling layers created by membrane proteins on goldD S Shah, M B Thomas, S Phillips, et al.
British Journal of Cancer|August 30, 2008
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancerP M Hoff, S Kopetz, M B Thomas, et al.
Nephron|January 1, 1992
Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failureA St John, M B Thomas, C P Davies, et al.
Oncogene|February 19, 1998
Characterization of the mouse Ron/Stk receptor tyrosine kinase geneS E Waltz, C L Toms, S A McDowell, et al.
Oncology|February 14, 2012
Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trialAhmed O Kaseb, E Garrett-Mayer, J S Morris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinomaM Simonelli, P Zucali, A Santoro, et al.
Pageof 5